METABOLIC SYNDROME AND PERIODONTITIS IN POSTMENOPAUSAL WOMEN

绝经后妇女的代谢综合征和牙周炎

基本信息

项目摘要

DESCRIPTION (provided by applicant): Metabolic syndrome (Metsyn) is a condition of coexisting abnormalities in glucose, lipid, blood pressure, and body fat homeostasis, that affects more than half of U.S. adults 55 years and older. Metsyn is a putative factor for modified host immune response and acceleration of periodontitis. Physical activity and weight loss ameliorate risk of certain Metsyn-related complications, but it is unknown if this extends to periodontal disease. In response to NIDCR PAR-09-182, we propose an extensive secondary data analysis on existing prospective data to examine associations of Metsyn, physical activity and body habitus with measures of prevalence and progression of periodontal disease in a cohort of postmenopausal women. We hypothesize that Metsyn will be associated with higher periodontal disease prevalence and greater progression; that higher physical activity levels and lower body fat levels will modify the association between Metsyn and periodontal disease; and that greater insulin sensitivity and lower systemic inflammatory are, in part, potential mechanisms through which higher physical activity and lower body fat modify the association between Metsyn and periodontitis. The study includes 660 postmenopausal women enrolled in a periodontal disease/osteoporosis study at the Buffalo (NY) center of the Women's Health Initiative. At baseline and at a 5-year reexamination, assessments included standardized oral probing measures and oral radiographs for alveolar crestal height (ACH); dual energy x-ray absorptiometry (DXA) for bone density and body composition; questionnaires on lifestyle habits, oral hygiene and medical history; resting blood pressure; and a fasting blood sample meticulously collected, processed and frozen, that have had relevant biomarkers measured. Our primary dependent variable is based on ACH changes; other periodontal outcomes also will be explored. Metsyn will be defined by National Cholesterol Education Program criteria, using measures of waist girth and/or BMI, blood pressure, and fasting glucose, triglyceride and HDL-C. Concentrations of insulin, and of C-reactive protein and interleukin-6, will be used in defining insulin sensitivity and systemic inflammation, respectively. Strengths are the prospective design and serial standardized oral examinations using calibrated examiners, the well-defined sample of postmenopausal women, DXA measures of body composition, and measured serum biomarkers. This offers advantages over epidemiological studies in which exposures and outcomes are assessed using only questionnaires, blood biomarkers are not available, or the temporal sequence of exposure and outcome assessment is not suitable for etiological hypothesis testing. The extensive database permits examination of confounding and interaction by relevant variables including smoking, medications, and usual dental care. The proposed study aligns with the NIDCR Strategic Plan to integrate molecular, clinical and population work to improve diagnostics and health outcomes. The existing resources for this secondary data analysis provide an unprecedented cost- efficient opportunity to build on established work and expand knowledge in this important area of public health.
描述(由申请人提供):代谢综合征(Metsyn)是一种葡萄糖、脂质、血压和体脂稳态共存异常的疾病,影响超过一半的55岁及以上的美国成年人。Metsyn是一个假定的因素,修改宿主免疫反应和加速牙周炎。体力活动和体重减轻可以改善某些Metsyn相关并发症的风险,但尚不清楚这是否会扩展到牙周病。为了响应NIDCR PAR-09-182,我们提出了一个广泛的二手数据分析现有的前瞻性数据,以检查协会的Metsyn,体力活动和身体形态与牙周病的患病率和进展的措施,在一个队列的绝经后妇女。我们假设,美泰生将与更高的牙周病患病率和更大的进展;更高的体力活动水平和更低的体脂水平将修改美泰生和牙周病之间的关联;更高的胰岛素敏感性和更低的全身炎症,部分是通过更高的体力活动和更低的体脂修改美泰生和牙周炎之间的关联的潜在机制。这项研究包括660名绝经后妇女参加了在布法罗(纽约)妇女健康倡议中心进行的牙周病/骨质疏松症研究。在基线和5年复查时,评估包括标准化口腔探查措施和牙槽嵴高度(ACH)的口腔X线片;骨密度和身体成分的双能X线吸收测定法(DXA);生活习惯,口腔卫生和病史的问卷调查;静息血压;以及精心收集,处理和冷冻的空腹血液样本,这些样本已测量相关生物标志物。我们的主要因变量是基于ACH的变化,其他牙周的结果也将进行探讨。Metsyn将由国家胆固醇教育计划标准定义,使用腰围和/或BMI、血压和空腹血糖、甘油三酯和HDL-C的测量值。胰岛素、C-反应蛋白和白细胞介素-6的浓度将用于定义 胰岛素敏感性和全身性炎症。优势是前瞻性设计和系列标准化的口腔检查,使用校准的考官,绝经后妇女的明确定义的样本,身体成分的DXA测量,并测量血清生物标志物。这与流行病学研究相比具有优势,在流行病学研究中,仅使用问卷评估暴露和结果,血液生物标志物不可用,或者暴露和结果评估的时间顺序不适合病因学假设检验。广泛的数据库允许检查相关变量的混杂和相互作用,包括吸烟,药物治疗和日常牙科护理。拟议的研究符合NIDCR战略计划,整合分子,临床和人口工作,以改善诊断和健康结果。用于这种二级数据分析的现有资源提供了一个前所未有的具有成本效益的机会,可以在这一重要的公共卫生领域的既定工作基础上再接再厉,扩大知识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael J LaMonte其他文献

Systolic Blood Pressure and Survival to Very Old Age: Results From the Women’s Health Initiative
收缩压和高龄生存:妇女健康倡议的结果
  • DOI:
    10.1161/circulationaha.123.067302
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    37.8
  • 作者:
    B. Haring;Chris A Andrews;K. Hovey;A. Shadyab;Andrea Z LaCroix;Lisa W. Martin;Milagros C. Rosal;Lewis H. Kuller;Elena Salmoirago;N. Saquib;Patrick Koo;Deepika R. Laddu;Marcia L Stefanick;J. E. Manson;S. Wassertheil;Michael J LaMonte
  • 通讯作者:
    Michael J LaMonte

Michael J LaMonte的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael J LaMonte', 18)}}的其他基金

METABOLIC SYNDROME AND PERIODONTITIS IN POSTMENOPAUSAL WOMEN
绝经后妇女的代谢综合征和牙周炎
  • 批准号:
    8283225
  • 财政年份:
    2012
  • 资助金额:
    $ 15.22万
  • 项目类别:
Coronary artery calcium, exercise tests, and CHD outcome
冠状动脉钙、运动测试和 CHD 结果
  • 批准号:
    6661230
  • 财政年份:
    1999
  • 资助金额:
    $ 15.22万
  • 项目类别:
Coronary artery calcium, exercise tests, and CHD outcome
冠状动脉钙、运动测试和 CHD 结果
  • 批准号:
    6786691
  • 财政年份:
    1999
  • 资助金额:
    $ 15.22万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 15.22万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.22万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 15.22万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.22万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 15.22万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 15.22万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.22万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 15.22万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 15.22万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.22万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了